Yigal Nochomovitz
Stock Analyst at Citigroup
(3.19)
# 1,066
Out of 4,870 analysts
298
Total ratings
39.46%
Success rate
2.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Buy | $49 → $41 | $17.58 | +133.22% | 15 | May 22, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $215 → $155 | $136.61 | +13.46% | 5 | May 16, 2025 | |
| ARVN Arvinas | Maintains: Neutral | $10 → $9.5 | $7.38 | +28.73% | 10 | May 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $10 | $3.59 | +178.55% | 15 | May 2, 2025 | |
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $20.47 | +70.98% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $30.84 | +52.40% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $12.46 | +52.49% | 16 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.78 | +192.86% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $9.23 | +355.04% | 8 | Mar 4, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $4.65 | +438.21% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $45.47 | +80.34% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $8.24 | +300.49% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $52.53 | +84.66% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.30 | +2,566.67% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $1.31 | +359.77% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $9.67 | +179.21% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.99 | +101.07% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $22.81 | +57.83% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $21.44 | +170.52% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $1.75 | +1,157.14% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.33 | +956.60% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.29 | +312.37% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $8.68 | +338.04% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $9.91 | +41.27% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.96 | +2.04% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $35.89 | +83.90% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $12.44 | +285.85% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.20 | +376.19% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $3.13 | +156.00% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.97 | -66.33% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $7.90 | +343.04% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $36.91 | +260.34% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.73 | +992.90% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.76 | +693.02% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.41 | +1,034.75% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.14 | +777.19% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.64 | +2,401.95% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.80 | +566.67% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.32 | - | 14 | Sep 28, 2021 |
Apellis Pharmaceuticals
May 22, 2025
Maintains: Buy
Price Target: $49 → $41
Current: $17.58
Upside: +133.22%
Krystal Biotech
May 16, 2025
Maintains: Neutral
Price Target: $215 → $155
Current: $136.61
Upside: +13.46%
Arvinas
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.38
Upside: +28.73%
Ardelyx
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.59
Upside: +178.55%
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $20.47
Upside: +70.98%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $30.84
Upside: +52.40%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $12.46
Upside: +52.49%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.78
Upside: +192.86%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $9.23
Upside: +355.04%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $4.65
Upside: +438.21%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $45.47
Upside: +80.34%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $8.24
Upside: +300.49%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $52.53
Upside: +84.66%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.30
Upside: +2,566.67%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.31
Upside: +359.77%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $9.67
Upside: +179.21%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.99
Upside: +101.07%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $22.81
Upside: +57.83%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $21.44
Upside: +170.52%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $1.75
Upside: +1,157.14%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.33
Upside: +956.60%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.29
Upside: +312.37%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $8.68
Upside: +338.04%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $9.91
Upside: +41.27%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.96
Upside: +2.04%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $35.89
Upside: +83.90%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $12.44
Upside: +285.85%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.20
Upside: +376.19%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $3.13
Upside: +156.00%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.97
Upside: -66.33%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $7.90
Upside: +343.04%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $36.91
Upside: +260.34%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.73
Upside: +992.90%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.76
Upside: +693.02%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.41
Upside: +1,034.75%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.14
Upside: +777.19%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.64
Upside: +2,401.95%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.80
Upside: +566.67%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.32
Upside: -